Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma	Recruiting	Phase 1	2025-02-11		NCT06613009

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Innovent Biologics (Suzhou) Co. Ltd.	82

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Austin Hospital	Heidelberg	Australia	37
Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital)	Jinan	China	4
Henan Cancer Hospital	Zhengzhou	China	76
Hunan Cancer Hospital	Changsha	China	41
The First affiliated Hospital of Anhui Medical University	Hefei	China	56
The First Affiliated Hospital of Fujian Medical University	Fuzhou	China	53
The First Affiliated Hospital of Nanchang University	Nanchang	China	109
Westmead Hospital	Westmead	Australia	128
Wollongong Hospital	Wollongong	Australia	29
Zhejiang Cancer Hospital	Hangzhou	China	34